Regeneron Pharmaceuticals, Inc.
ANTI- PDGF-B ANTIBODIES AND METHODS OF USE FOR TREATING PULMONARY ARTERIAL HYPERTENSION (PAH)
Last updated:
Abstract:
The present disclosure provides anti-Platelet-Derived Growth Factor Subunit B (PDGF-B) antibodies, and antigen-binding fragments thereof, as well as methods of use of such antibodies, or antigen-binding fragments thereof, for treating a subject having pulmonary arterial hypertension (PAH).
Status:
Application
Type:
Utility
Filling date:
25 Jan 2022
Issue date:
4 Aug 2022